Venclexta is a Kit in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is .
Product ID | 0074-0579_2284c7ad-cd64-4d4c-0355-1e21172bba43 |
NDC | 0074-0579 |
Product Type | Human Prescription Drug |
Proprietary Name | Venclexta |
Generic Name | Venetoclax |
Dosage Form | Kit |
Marketing Start Date | 2016-04-11 |
Marketing Category | NDA / NDA |
Application Number | NDA208573 |
Labeler Name | AbbVie Inc. |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2016-04-11 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208573 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-04-11 |
SPL SET ID: | b118a40d-6b56-cee3-10f6-ded821a97018 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0074-0561 | Venclexta | Venetoclax |
0074-0566 | Venclexta | Venetoclax |
0074-0576 | Venclexta | Venetoclax |
0074-0579 | Venclexta | Venetoclax |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VENCLEXTA 86855625 5079634 Live/Registered |
AbbVie Inc. 2015-12-21 |
VENCLEXTA 86560752 5078740 Live/Registered |
AbbVie Inc. 2015-03-11 |